Improved Visualization of Hepatic Tumors in Magnetic Resonance-guided Thermoablation Using T1-inversion-recovery Imaging with Variable Inversion Time

Overview

Journal Eur Radiol

Specialty Radiology

Date 2023 May 3

PMID 37133519

Authors

J Kubler

P Krumm

P Martirosian

M T Winkelmann

G Gohla

K Nikolaou

R Hoffmann

Affiliations

Soon will be listed here.

Abstract

Objectives: In magnetic resonance (MR)-guided interventions, visualization of hepatic lesions may be difficult using standard unenhanced T1-weighted gradient-echo volume-interpolated breath-hold (VIBE) sequence due to low contrast. Inversion recovery (IR) imaging may have the potential to improve visualization without the necessity to apply contrast agent.

Methods: Forty-four patients (mean age 64 years, female 33%) scheduled for MR-guided thermoablation due to liver malignancies (hepatocellular carcinoma or metastases) were prospectively included in this study between March 2020 and April 2022. Fifty-one liver lesions were intra-procedurally characterized before treatment. Unenhanced T1-VIBE was acquired as part of the standard imaging protocol. Additionally, T1-modified look-locker images were acquired with eight different inversion times (TI) between 148 and 1743 ms. Lesion-to-liver contrast (LLC) was compared between T1-VIBE and IR images for each TI. T1 relaxation times for liver lesions and liver parenchyma were calculated.

Results: Mean LLC in T1-VIBE sequence was 0.3 ± 0.1. In IR images, LLC was highest at TI 228 ms (1.04 ± 1.1) and significantly higher compared to T1-VIBE (p < 0.001). In subgroup analysis, lesions of colorectal carcinoma showed the highest LLC at 228 ms (1.14 ± 1.4), and hepatocellular carcinoma showed the highest LLC at 548 ms (1.06 ± 1.16). T1-relaxation times in liver lesions were higher compared to the adjacent liver parenchyma (1184 ± 456 vs. 654 ± 96 ms, p < 0.001).

Conclusions: IR imaging is promising to provide improved visualization during unenhanced MR-guided liver interventions compared to standard T1-VIBE sequence when using specific TI. Low TI between 150 and 230 ms yields the highest contrast between liver parenchyma and malignant liver lesions.

Clinical Relevance Statement: Improved visualization of hepatic lesions during MR-guided percutaneous interventions using inversion recovery imaging without the necessity to apply contrast agent.

Key Points: • Inversion recovery imaging is promising to provide improved visualization of liver lesions in unenhanced MRI. • Planning and guidance during MR-guided interventions in the liver can be performed with greater confidence without necessity to apply contrast agent. • Low TI between 150 and 230 ms yields the highest contrast between liver parenchyma and malignant liver lesions.

References

Rempp H, Loh H, Hoffmann R, Rothgang E, Pan L, Claussen C . Liver lesion conspicuity during real-time MR-guided radiofrequency applicator placement using spoiled gradient echo and balanced steady-state free precession imaging. J Magn Reson Imaging. 2014; 40(2):432-9. DOI: 10.1002/jmri.24371. View

Winkelmann M, Gohla G, Kubler J, Weiss J, Clasen S, Nikolaou K . MR-Guided High-Power Microwave Ablation in Hepatic Malignancies: Initial Results in Clinical Routine. Cardiovasc Intervent Radiol. 2020; 43(11):1631-1638. PMC: 7591402. DOI: 10.1007/s00270-020-02584-5. View

Foldyna B, Szilveszter B, Scholtz J, Banerji D, Maurovich-Horvat P, Hoffmann U . CAD-RADS - a new clinical decision support tool for coronary computed tomography angiography. Eur Radiol. 2017; 28(4):1365-1372. PMC: 6438206. DOI: 10.1007/s00330-017-5105-4. View

Donato H, Franca M, Candelaria I, Caseiro-Alves F . Liver MRI: From basic protocol to advanced techniques. Eur J Radiol. 2017; 93:30-39. DOI: 10.1016/j.ejrad.2017.05.028. View

Bashir M . Magnetic resonance contrast agents for liver imaging. Magn Reson Imaging Clin N Am. 2014; 22(3):283-93. DOI: 10.1016/j.mric.2014.04.002. View

Do R, Rusinek H, Taouli B . Dynamic contrast-enhanced MR imaging of the liver: current status and future directions. Magn Reson Imaging Clin N Am. 2009; 17(2):339-49. DOI: 10.1016/j.mric.2009.01.009. View

Ghoshhajra B, Takx R, Staziaki P, Vadvala H, Kim P, Neilan T . Clinical implementation of an emergency department coronary computed tomographic angiography protocol for triage of patients with suspected acute coronary syndrome. Eur Radiol. 2016; 27(7):2784-2793. PMC: 5976244. DOI: 10.1007/s00330-016-4562-5. View

Sironi S, Livraghi T, Meloni F, De Cobelli F, Ferrero C, Del Maschio A . Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR Am J Roentgenol. 1999; 173(5):1225-9. DOI: 10.2214/ajr.173.5.10541093. View

Dromain C, De Baere T, Elias D, Kuoch V, Ducreux M, Boige V . Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology. 2002; 223(1):255-62. DOI: 10.1148/radiol.2231010780. View

10.

Rempp H, Clasen S, Pereira P . Image-based monitoring of magnetic resonance-guided thermoablative therapies for liver tumors. Cardiovasc Intervent Radiol. 2011; 35(6):1281-94. DOI: 10.1007/s00270-011-0227-6. View

11.

Rashid S, Rapacchi S, Shivkumar K, Plotnik A, Finn J, Hu P . Modified wideband three-dimensional late gadolinium enhancement MRI for patients with implantable cardiac devices. Magn Reson Med. 2015; 75(2):572-84. PMC: 4661130. DOI: 10.1002/mrm.25601. View

12.

Bydder G, Young I . MR imaging: clinical use of the inversion recovery sequence. J Comput Assist Tomogr. 1985; 9(4):659-75. View

13.

Varga-Szemes A, van der Geest R, Schoepf U, Spottiswoode B, De Cecco C, Muscogiuri G . Effect of inversion time on the precision of myocardial late gadolinium enhancement quantification evaluated with synthetic inversion recovery MR imaging. Eur Radiol. 2017; 27(8):3235-3243. DOI: 10.1007/s00330-016-4665-z. View

14.

Simonetti O, Kim R, Fieno D, Hillenbrand H, Wu E, Bundy J . An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001; 218(1):215-23. DOI: 10.1148/radiology.218.1.r01ja50215. View

15.

Ghasemi A, Zahediasl S . Normality tests for statistical analysis: a guide for non-statisticians. Int J Endocrinol Metab. 2013; 10(2):486-9. PMC: 3693611. DOI: 10.5812/ijem.3505. View

16.

Yutzy S, Duerk J . Pulse sequences and system interfaces for interventional and real-time MRI. J Magn Reson Imaging. 2008; 27(2):267-75. DOI: 10.1002/jmri.21268. View

17.

Boss A, Clasen S, Kuczyk M, Anastasiadis A, Schmidt D, Claussen C . [Radiofrequency ablation of renal cell carcinomas using MR imaging: initial results]. Rofo. 2005; 177(8):1139-45. DOI: 10.1055/s-2005-858320. View

18.

Messroghli D, Radjenovic A, Kozerke S, Higgins D, Sivananthan M, Ridgway J . Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med. 2004; 52(1):141-6. DOI: 10.1002/mrm.20110. View